Xiaoping Ye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaoping Ye has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Hong Liu
Department of Vascular Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; Department of Day Service Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
3 shared publications Xiaoya Liu
Department of Oncology, Key Laboratory of Immunity, Inflammation & Cancer (Chongqing Municipal Health Commission), The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China
3 shared publicationsXiang Zhang
Department of Oncology, Key Laboratory of Immunity, Inflammation & Cancer (Chongqing Municipal Health Commission), The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China
2 shared publications- Xianxian Zhao
Central Laboratory, Chongqing University FuLing Hospital, Chongqing 408099, China
2 shared publications - Yuyu Fang
School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
2 shared publications Arlene McDowell
School of Pharmacy, University of Otago, Dunedin 9054, New Zealand
1 shared publication
Latest Publications
- 15 July 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 312, 119027
A dual-recognition fluorescence chip utilizing a substrate-borne DNA walker for precision profiling of small extracellular vesicles
- 15 July 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 312, 119027
A dual-recognition fluorescence chip utilizing a substrate-borne DNA walker for precision profiling of small extracellular vesicles
- 15 April 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (16) , 9000-9007
A Versatile Colorimetric Diagnostic Platform Based on Primer Exchange Reaction Cascades Driven Loop-Mediated Isothermal Amplification
The primer exchange reaction (PER), as a well-established and sophisticated isothermal nucleic acid amplification strategy, has been extensively employed to amplify various genetic biomarkers. However, the amplification efficiency of conventional PER is generally unsatisfactory due to its linear signal-amplifying mechanism. In this study, we developed a versatile colorimetric platform by rationally integrating Primer exchange reaction with efficient Loop-mediated isothermal amplification (LAMP), termed vcPeLa, for the rapid and sensitive detection of cancer-related biomarkers, such as microRNAs (miRNAs) and carcinoembryonic antigen (CEA). The PER cascade in the vcPeLa can be directly initiated by the target, resulting in the production of long single-stranded DNA products with repeated functional sections. These repeats in the product can serve as the template to produce a significant number of double stem-loop DNAs with the cooperation of DNA polymerase and hairpin structure primer probes. These DNAs are the primary starting materials for subsequent LAMP. A substantial quantity of pyrophosphate can be recognized by Cu2+-chelated pp Probe (pyrophosphate sensing probe). The Cu2+ is removed from the Cu2+-chelated pp Probe as a result of the formation of a complex between Cu2+ and pyrophosphate, which results in color changes. Consequently, the vcPeLa platform is feasible to detect 0.31 fM miRNA and 0.043 ng/mL CEA with high selectivity and stability without the requirement of introducing any additional reaction steps or sample transfer operations in comparison to conventional assays. Therefore, this facile and ultrasensitive vcPeLa platform provides a new promising tool for cancer diagnosis and biomarker screening.
- 15 April 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (16) , 9000-9007
A Versatile Colorimetric Diagnostic Platform Based on Primer Exchange Reaction Cascades Driven Loop-Mediated Isothermal Amplification
The primer exchange reaction (PER), as a well-established and sophisticated isothermal nucleic acid amplification strategy, has been extensively employed to amplify various genetic biomarkers. However, the amplification efficiency of conventional PER is generally unsatisfactory due to its linear signal-amplifying mechanism. In this study, we developed a versatile colorimetric platform by rationally integrating Primer exchange reaction with efficient Loop-mediated isothermal amplification (LAMP), termed vcPeLa, for the rapid and sensitive detection of cancer-related biomarkers, such as microRNAs (miRNAs) and carcinoembryonic antigen (CEA). The PER cascade in the vcPeLa can be directly initiated by the target, resulting in the production of long single-stranded DNA products with repeated functional sections. These repeats in the product can serve as the template to produce a significant number of double stem-loop DNAs with the cooperation of DNA polymerase and hairpin structure primer probes. These DNAs are the primary starting materials for subsequent LAMP. A substantial quantity of pyrophosphate can be recognized by Cu2+-chelated pp Probe (pyrophosphate sensing probe). The Cu2+ is removed from the Cu2+-chelated pp Probe as a result of the formation of a complex between Cu2+ and pyrophosphate, which results in color changes. Consequently, the vcPeLa platform is feasible to detect 0.31 fM miRNA and 0.043 ng/mL CEA with high selectivity and stability without the requirement of introducing any additional reaction steps or sample transfer operations in comparison to conventional assays. Therefore, this facile and ultrasensitive vcPeLa platform provides a new promising tool for cancer diagnosis and biomarker screening.
- Open Access
- 4 December 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (50) , 49081-49087
Rolling Circle Amplification Integrating with Exonuclease-III-Assisted Color Reaction for Sensitive Telomerase Activity Analysis
Telomerase activation can lead to the escape from cell senescence and immortalization, playing a crucial role in the growth and proliferation of cancer cells. Therefore, the detection of telomerase activity is essential for cancer diagnosis and treatment. Herein, we develop a novel ultrasensitive and visually detectable platform. By incorporation of exonuclease-III (Exo-III), this platform achieves dual signal amplification of rolling circle amplification products. Additionally, the colorimetric analysis of 3,3',5,5'-tetramethylbiphenyl (TMB) chromogenic reaction system provides this approach with unique advantages such as simplicity, speediness, and sensitivity. The detection platform exhibits high sensitivity and specificity in actual sample testing, which aligns closely with results obtained using commercial kits. Moreover, it offers ease-of-use through visual determination by the naked eyes. This finding indicates that our proposed sensing method performs satisfactorily in detecting telomerase in real biological samples. Henceforth, we believe that this sensing platform holds great potential for clinical diagnosis and anticancer drug development.
- 4 December 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (50) , 49081-49087
Open AccessRolling Circle Amplification Integrating with Exonuclease-III-Assisted Color Reaction for Sensitive Telomerase Activity Analysis
Telomerase activation can lead to the escape from cell senescence and immortalization, playing a crucial role in the growth and proliferation of cancer cells. Therefore, the detection of telomerase activity is essential for cancer diagnosis and treatment. Herein, we develop a novel ultrasensitive and visually detectable platform. By incorporation of exonuclease-III (Exo-III), this platform achieves dual signal amplification of rolling circle amplification products. Additionally, the colorimetric analysis of 3,3',5,5'-tetramethylbiphenyl (TMB) chromogenic reaction system provides this approach with unique advantages such as simplicity, speediness, and sensitivity. The detection platform exhibits high sensitivity and specificity in actual sample testing, which aligns closely with results obtained using commercial kits. Moreover, it offers ease-of-use through visual determination by the naked eyes. This finding indicates that our proposed sensing method performs satisfactorily in detecting telomerase in real biological samples. Henceforth, we believe that this sensing platform holds great potential for clinical diagnosis and anticancer drug development.
- Open Access
- 22 October 2024
- Published by MDPI AG in Biosensors
- Vol. 14 (11) , 515
The First N,O-Chelated Diphenylboron-Based Fluorescent Probe for Peroxynitrite and Its Bioimaging Applications
Peroxynitrite (ONOO−) is a reactive oxygen species (ROS) that takes part in the oxidation-reduction homeostasis while at the same time being responsible for activating numerous pathological pathways. Accordingly, monitoring the dynamic changes in ONOO− concentration has attracted a great deal of attention, undoubtedly prompting the development of appropriate fluorescent chemosensors. Herein, we developed a novel N,O-chelated diphenylboron-based fluorescent probe (DPB) for ONOO− featuring high selectivity, a quick response time (2.0 min), and a low detection limit (55 nM). DPB incorporates tetra-coordinated boron in the center of the fluorogenic core and a three-coordinated boron from the pinacolphenylboronate fragment, which acts as the recognition site for ONOO−. As confirmed by HR-MS and 1H NMR, the interaction of DPB with ONOO− led to an oxidative cleavage of pinacolphenylboronate moiety to produce strongly emissive derivative DPB-OH. The fluorescence enhancement is likely a result of a substantial deactivation of non-radiative decay due to the replacement of the bulky pinacolphenylboronate moiety with a compact hydroxyl group. Importantly, DPB probe exhibits negligible cytotoxicity and favorable biocompatibility allowing for an efficient tracking of ONOO− in living cells and zebrafish. Overall, the current study does not only represents the first N,O-chelated diphenylboron-based fluorescent probe for a specific analyte, but also serves as a guideline for designing more potent fluorescent probes based on the chemistry of boron chelates.
- 22 October 2024
- Published by MDPI AG in Biosensors
- Vol. 14 (11) , 515
Open AccessThe First N,O-Chelated Diphenylboron-Based Fluorescent Probe for Peroxynitrite and Its Bioimaging Applications
Peroxynitrite (ONOO−) is a reactive oxygen species (ROS) that takes part in the oxidation-reduction homeostasis while at the same time being responsible for activating numerous pathological pathways. Accordingly, monitoring the dynamic changes in ONOO− concentration has attracted a great deal of attention, undoubtedly prompting the development of appropriate fluorescent chemosensors. Herein, we developed a novel N,O-chelated diphenylboron-based fluorescent probe (DPB) for ONOO− featuring high selectivity, a quick response time (2.0 min), and a low detection limit (55 nM). DPB incorporates tetra-coordinated boron in the center of the fluorogenic core and a three-coordinated boron from the pinacolphenylboronate fragment, which acts as the recognition site for ONOO−. As confirmed by HR-MS and 1H NMR, the interaction of DPB with ONOO− led to an oxidative cleavage of pinacolphenylboronate moiety to produce strongly emissive derivative DPB-OH. The fluorescence enhancement is likely a result of a substantial deactivation of non-radiative decay due to the replacement of the bulky pinacolphenylboronate moiety with a compact hydroxyl group. Importantly, DPB probe exhibits negligible cytotoxicity and favorable biocompatibility allowing for an efficient tracking of ONOO− in living cells and zebrafish. Overall, the current study does not only represents the first N,O-chelated diphenylboron-based fluorescent probe for a specific analyte, but also serves as a guideline for designing more potent fluorescent probes based on the chemistry of boron chelates.
- Open Access
- 22 December 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 1095711
Wnt16 signaling in bone homeostasis and osteoarthristis
Wnts are secreted cysteine-rich glycoproteins involved in joint development and skeletal homeostasis and have been implicated in the occurrence of osteoarthritis. Over the past decade, Wnt16, a member of the Wnt family, has received widespread attention for its strong association with bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. In recent years, further studies have shed light on the role of Wnt16 a positive regulator of bone mass and protective regulator of osteoarthritis progression. Transduction mechanisms and crosstalk involving Wnt16 signaling have also been illustrated. More importantly, local Wnt16 treatment has been shown to ease osteoarthritis, inhibit bone resorption, and promote new bone formation in bone defect models. Thus, Wnt16 is now a potential therapeutic target for skeletal diseases and osteoarthritis. This paper reviews our current understanding of the mechanisms by which Wnt16 signaling regulates bone homeostasis and osteoarthritis.
- 22 December 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 1095711
Open AccessWnt16 signaling in bone homeostasis and osteoarthristis
Wnts are secreted cysteine-rich glycoproteins involved in joint development and skeletal homeostasis and have been implicated in the occurrence of osteoarthritis. Over the past decade, Wnt16, a member of the Wnt family, has received widespread attention for its strong association with bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. In recent years, further studies have shed light on the role of Wnt16 a positive regulator of bone mass and protective regulator of osteoarthritis progression. Transduction mechanisms and crosstalk involving Wnt16 signaling have also been illustrated. More importantly, local Wnt16 treatment has been shown to ease osteoarthritis, inhibit bone resorption, and promote new bone formation in bone defect models. Thus, Wnt16 is now a potential therapeutic target for skeletal diseases and osteoarthritis. This paper reviews our current understanding of the mechanisms by which Wnt16 signaling regulates bone homeostasis and osteoarthritis.
- Open Access
- 12 February 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (6) , e24570
Intravenous pyogenic granuloma in the internal jugular vein
Rationale: Intravenous pyogenic granuloma (IVPG) is a special type of pyogenic granuloma, and its preoperative diagnosis is difficult. We report a rare case of IVPG that develops in the lumen of the internal jugular vein (IJV). Here, we analyze the imaging characteristics of present case and summarize the imaging characteristics of previous reported cases. Patient concerns: A 44-year-old man who presented with a growth in the IJV without any symptoms. Diagnoses: A diagnosis of IVPG was made, based on the pathological examination after surgery. Interventions: The patient underwent surgery to excise the vein segment containing the neoplasm. Outcomes: The patient did not present with any complications in the postoperative follow-up period. Lessons: For clinician, IVPG's preoperative diagnosis is difficult. Although histopathology remains the gold standard for diagnosis, the combination of multiple types of imaging examinations is necessary to rule out the differential diagnoses of IVPG.
- 12 February 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (6) , e24570
Open AccessIntravenous pyogenic granuloma in the internal jugular vein
Rationale: Intravenous pyogenic granuloma (IVPG) is a special type of pyogenic granuloma, and its preoperative diagnosis is difficult. We report a rare case of IVPG that develops in the lumen of the internal jugular vein (IJV). Here, we analyze the imaging characteristics of present case and summarize the imaging characteristics of previous reported cases. Patient concerns: A 44-year-old man who presented with a growth in the IJV without any symptoms. Diagnoses: A diagnosis of IVPG was made, based on the pathological examination after surgery. Interventions: The patient underwent surgery to excise the vein segment containing the neoplasm. Outcomes: The patient did not present with any complications in the postoperative follow-up period. Lessons: For clinician, IVPG's preoperative diagnosis is difficult. Although histopathology remains the gold standard for diagnosis, the combination of multiple types of imaging examinations is necessary to rule out the differential diagnoses of IVPG.
- Open Access
- 20 January 2021
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 21 (1) , 1-7
Doppler ultrasound and contrast-enhanced ultrasound in detection of stent stenosis after iliac vein stenting
Background: To compare the diagnostic accuracy of Doppler ultrasound (DUS) with contrast-enhanced ultrasound (CEUS) for detection of iliac vein stent stenosis using multidetector computed tomography venography (MDCTV) as the reference method. Methods: Patients with iliac vein obstructive disease treated with nitinol stents (Smart Control, Cordis, USA) between January 2016 and December 2017 were consecutively included in this study. DUS, CEUS, and MDCTV were carried out in all patients within one week of each other at 1 year post stenting to investigate the presence of stent compression and in-stent restenosis (ISR). Results: The study included 139 patients (87 females; mean age 58 ± 15 years). For detecting stent compression, the kappa coefficient between the ultrasound modality of gray-scale imaging and MDCTV was 0.901, indicating very good agreement between these two modalities. ISR was detected in 50, 61, and 65 patients by DUS, CEUS, and MDCTV, respectively. DUS and CEUS (kappa = 0.449) and DUS and MDCTV (kappa = 0.516) had moderate agreement for ISR diagnosis, while for which CEUS and MDCTV (kappa 0.884) had very good agreement. The sensitivity and specificity of DUS and CEUS for diagnosing ISR were 63.1% and 90.8%, 87.8% and 97.3%, respectively. Conclusions: CEUS is probably superior to DUS in terms of diagnostic accuracy for the follow-up of patients with iliac vein stent stenosis.
- 20 January 2021
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 21 (1) , 1-7
Open AccessDoppler ultrasound and contrast-enhanced ultrasound in detection of stent stenosis after iliac vein stenting
Background: To compare the diagnostic accuracy of Doppler ultrasound (DUS) with contrast-enhanced ultrasound (CEUS) for detection of iliac vein stent stenosis using multidetector computed tomography venography (MDCTV) as the reference method. Methods: Patients with iliac vein obstructive disease treated with nitinol stents (Smart Control, Cordis, USA) between January 2016 and December 2017 were consecutively included in this study. DUS, CEUS, and MDCTV were carried out in all patients within one week of each other at 1 year post stenting to investigate the presence of stent compression and in-stent restenosis (ISR). Results: The study included 139 patients (87 females; mean age 58 ± 15 years). For detecting stent compression, the kappa coefficient between the ultrasound modality of gray-scale imaging and MDCTV was 0.901, indicating very good agreement between these two modalities. ISR was detected in 50, 61, and 65 patients by DUS, CEUS, and MDCTV, respectively. DUS and CEUS (kappa = 0.449) and DUS and MDCTV (kappa = 0.516) had moderate agreement for ISR diagnosis, while for which CEUS and MDCTV (kappa 0.884) had very good agreement. The sensitivity and specificity of DUS and CEUS for diagnosing ISR were 63.1% and 90.8%, 87.8% and 97.3%, respectively. Conclusions: CEUS is probably superior to DUS in terms of diagnostic accuracy for the follow-up of patients with iliac vein stent stenosis.
- Open Access
- 2 October 2020
- Published by Springer Nature in Research Square
Doppler ultrasound and contrast-enhanced ultrasound in detection of stent stenosis after iliac vein stenting
Background: To compare the diagnostic accuracy of Doppler ultrasound (DUS) with contrast-enhanced ultrasound (CEUS) for detection of iliac vein stent stenosis using multidetector computed tomography venography (MDCTV) as the reference method.Methods: Patients with iliac vein obstructive disease treated with nitinol stents between January 2016 and December 2017 were consecutively included in this study. DUS, CEUS, and MDCTV were carried out in all patients within one week of each other at one year post stenting to investigate the presence of stent compression and in-stent restenosis (ISR). Results: The study included 139 patients (87 females; mean age 58 ± 15 years). For detecting stent compression, the kappa coefficient between the ultrasound modality of gray-scale imaging and MDCTV was 0.901, indicating very good agreement between these two modalities. ISR was detected in 50, 61, and 65 patients by DUS, CEUS, and MDCTV, respectively. DUS and CEUS (kappa=0.449) and DUS and MDCTV (kappa=0.516) had moderate agreement for ISR diagnosis, while for which CEUS and MDCTV (kappa 0.884) had very good agreement. The sensitivity, specificity, positive and negative predictive values of DUS and CEUS for diagnosing ISR were 63.1% and 90.8%, 87.8% and 97.3%, 82.0% and 96.7%, and 73.0% and 92.3%, respectively.Conclusions: CEUS is superior to DUS in terms of diagnostic accuracy for the follow-up of patients with iliac vein stent stenosis.
- 2 October 2020
- Published by Springer Nature in Research Square
Open AccessDoppler ultrasound and contrast-enhanced ultrasound in detection of stent stenosis after iliac vein stenting
Background: To compare the diagnostic accuracy of Doppler ultrasound (DUS) with contrast-enhanced ultrasound (CEUS) for detection of iliac vein stent stenosis using multidetector computed tomography venography (MDCTV) as the reference method.Methods: Patients with iliac vein obstructive disease treated with nitinol stents between January 2016 and December 2017 were consecutively included in this study. DUS, CEUS, and MDCTV were carried out in all patients within one week of each other at one year post stenting to investigate the presence of stent compression and in-stent restenosis (ISR). Results: The study included 139 patients (87 females; mean age 58 ± 15 years). For detecting stent compression, the kappa coefficient between the ultrasound modality of gray-scale imaging and MDCTV was 0.901, indicating very good agreement between these two modalities. ISR was detected in 50, 61, and 65 patients by DUS, CEUS, and MDCTV, respectively. DUS and CEUS (kappa=0.449) and DUS and MDCTV (kappa=0.516) had moderate agreement for ISR diagnosis, while for which CEUS and MDCTV (kappa 0.884) had very good agreement. The sensitivity, specificity, positive and negative predictive values of DUS and CEUS for diagnosing ISR were 63.1% and 90.8%, 87.8% and 97.3%, 82.0% and 96.7%, and 73.0% and 92.3%, respectively.Conclusions: CEUS is superior to DUS in terms of diagnostic accuracy for the follow-up of patients with iliac vein stent stenosis.
- 11 March 2020
- Published by Springer Nature in Research in Engineering Design
- Vol. 31 (2) , 235-255
Software-physical synergetic design methodology of mechatronic systems based on formal functional models
- 11 March 2020
- Published by Springer Nature in Research in Engineering Design
- Vol. 31 (2) , 235-255
Software-physical synergetic design methodology of mechatronic systems based on formal functional models